RecruitingNCT07503236

ENHANCE EFS

Early Feasibility Study (EFS) of the Nyra Cardiac Leaflet Enhancer (CARLEN) System

Nyra Medical, Inc.Multiple US sitesView on ClinicalTrials.gov

AI Description

Safety and performance evaluation of the CARLEN System in patients with functional mitral valve regurgitation.

Report inaccurate information

Who can join
adult, older adult
Participants
30
Expected completion
2032-12
Funded by
industry

Conditions studied

Mitral Regurgitation Functional

What is being tested

  • DEVICE: CARLEN System

What it measures

  • Primary Endpoint, Freedom from device- or procedure-related serious adverse events through 30-days post-procedure, 30-days post-procedure

Centers Participating

These centers are participating in this study. Reach out to them directly to learn more.

Data Sources and Methodology

Registry entry updated 2026-07-28

Deciding whether to join a study is your choice, and you can ask a study team questions before you decide anything.

If you would rather we did it with you, call us on (656) 206-4686.